Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shock

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 860-866

  Sakaguchi, Shinya ^a   Negishi, Hideo ^a   Asagiri, Masataka ^a,b   Nakajima, Chigusa ^a   Mizutani, Tatsuaki ^a   Takaoka, Akinori ^a   Honda, Kenya ^a   Taniguchi, Tadatsugu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endotoxin shock; IFN ; IRF 3; IRF 7; LPS; TLR4

Indexed keywords

BETA INTERFERON; CHEMOKINE; CYTOKINE; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SIMULATION;

BACTERIA (MICROORGANISMS);

EID: 0038434274     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01049-0     Document Type: Article

References (38)

1. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
2. Imler J.L., Hoffmann J.A. Toll receptors in innate immunity. Trends Cell. Biol. 11:2001;304-311.
3. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
4. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:2001;732-738.
5. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
6. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S., van der Heiden A., Itie A., Wakeham A., Khoo W., Sasaki T., Cao Z., Penninger J.M., Paige C.J., Lacey D.L., Dunstan C.R., Boyle W.J., Goeddel D.V., Mak T.W. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
7. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
8. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:2001;5887-5894.
9. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:2002;6668-6672.
10. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:2003;161-167.
11. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell Biol. 18:1998;2986-2996.
12. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:2003;491-496.
13. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Hiscott H. Triggering the interferon antiviral response through an IKK-related pathway. Science. 300:2003;1148-1151.
14. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:2001;623-655.
15. Fan C.M., Maniatis T. Two different virus-inducible elements are required for human. β -interferon gene regulation EMBO J. 8:1989;101-110.
16. Leblanc J.F., Cohen L., Rodrigues M., Hiscott J. Synergism between distinct enhanson domains in viral induction of the human. β interferon gene Mol. Cell. Biol. 10:1990;3987-3993.
17. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-. α/β gene induction Immunity. 13:2000;539-548.
18. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-. α genes by positive feedback through interferon regulatory factor-7 EMBO J. 17:1998;6660-6669.
19. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702.
21. Sato M., Tanaka N., Hata N., Oda E., Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-. β gene FEBS Lett. 425:1998;112-116.
22. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441:1998;106-110.
23. Ogasawara K., Hida S., Weng Y., Saiura A., Sato K., Takayanagi H., Sakaguchi S., Yokochi T., Kodama T., Naitoh M., De Martino J.A., Taniguchi T. Requirement of the IFN-. α/β induced CXCR3 chemokine signalling for CD8+ T cell activation Genes Cells. 7:2002;309-320.
24. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-. β gene regulatory elements EMBO J. 7:1988;3397-3405.
25. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-. β gene regulatory elements Cell. 54:1988;903-913.
26. Ryals J., Dierks P., Ragg H., Weissmann C. A 46-nucleotide promoter segment from an IFN-. α gene renders an unrelated promoter inducible by virus Cell. 41:1985;497-507.
27. Raj N.B., Israeli R., Kellum M., Pitha P.M. Upstream regulatory elements of murine. α 4-interferon gene confer inducibility and cell type-restricted expression J. Biol. Chem. 264:1989;11149-11157.
28. Genin P., Braganca J., Darracq N., Doly J., Civas A. A novel PRD I and TG binding activity involved in virus-induced transcription of IFN-. α genes Nucleic Acids Res. 23:1995;5055-5063.
29. Stewart II W.E., Gosser L.B., Lockart R.Z. Jr. Priming: a nonantiviral function of interferon. J. Virol. 7:1971;792-801.
30. Mattei F., Schiavoni G., Belardelli F., Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:2001;1179-1187.
31. Nakaya T., Sato M., Hata N., Asagiri M., Suemori H., Noguchi S., Tanaka N., Taniguchi T. Gene induction pathways mediated by distinct IRFs during viral infection. Biochem. Biophys. Res. Commun. 283:2001;1150-1156.
32. Karaghiosoff M., Steinborn R., Kovarik P., Kriegshauser G., Baccarini M., Donabauer B., Reichart U., Kolbe T., Bogdan C., Leanderson T., Levy D., Decker T., Muller M. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat. Immunol. 4:2003;471-477.
33. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837.
34. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:2001;1144-1150.
35. Fantuzzi G., Zheng H., Faggioni R., Benigni F., Ghezzi P., Sipe J.D., Shaw A.R., Dinarello C.A. Effect of endotoxin in IL-1β-deficient mice. J. Immunol. 157:1996;291-296.
36. Kobierski L.A., Srivastava S., Borsook D. Systemic lipopolysaccharide and interleukin-1β activate the interleukin 6: STAT intracellular signaling pathway in neurons of mouse trigeminal ganglion. Neurosci. Lett. 281:2000;61-64.
37. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Kronke M., Mak T.W. Mice deficient for the 55. kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell. 73:1993;457-467.
38. Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen F., Althage A., Zinkernagel R., Steinmetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364:1993;798-802.